Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Long-Term Care Out of Reach for 6.5 Million 'Near Dual' American Seniors

About 6.5 million Near Dual seniors are struggling to afford long-term care as they grow older and more frail, a new study warns. Near Dual seniors are those wh

Change in Alzheimer's Drug Vial Size Could Be Big Money-Saver for Medicare

A simple tweak in available vial sizes of the breakthrough Alzheimer s drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysi

GLP-1 Weight-Loss Meds, Wegovy, Zepbound, Won't Raise Teens' Suicide Risk, May Even Lower It

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the ri

A Boozy Night Out Could Upset Your Heart's Rhythm

Binge drinking at a party or club could feel great when the music s beating, but it s your heart beat that might pay the price. Researchers in Germany found tha

More Bystanders Are Using Naloxone to Save Folks From Overdose

More bystanders are stepping in to administer naloxone to people who ve overdosed on opioids, a new study shows. Nearly 25,000 OD patients received naloxone fro

Ozempic Plus Intestinal 'Zap' Therapy May Eliminate Need for Insulin in Type 2 Diabetics

Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for

1 in 4 U.S. Adults Suspect They Have Undiagnosed ADHD

Alison Burke wanted to be there for her daughter following the girl s diagnosis with attention-deficit hyperactivity disorder (ADHD). Then she noticed that a lo

Most ERs Not Fully Equipped to Treat Pediatric Patients

New findings may worry many parents Nearly 8 in 10 emergency rooms lack the supplies and training needed to treat pediatric patients, new U.S. research shows. T

FDA Grants Fast Track Designation For Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depression (TRD)

Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced that the US Food and Drug Administration (FDA

Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis

Mirum Pharmaceuticals, Inc. (Nasdaq MIRM) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to volix

Popular Keywords